Literature DB >> 15315758

One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers.

Thomas H Leung1, Alexander Hoffmann, David Baltimore.   

Abstract

The transcription factor NF-kappaB regulates a wide variety of genes involved in multiple processes. Although the apparent consensus sequence of DNA binding sites for NF-kappaB (kappaB sites) is very broad, the sites active in any one gene show remarkable evolutionary stability. Using a lentivirus-based methodology for implantation of gene regulatory sequences we show that for genes with two kappaB sites, both are required for activity. Swapping sites between kappaB-dependent genes altered NF-kappaB dimer specificity of the promoters and revealed that two kappaB sites can function together as a module to regulate gene activation. Further, although the sequence of the kappaB site is important for determining kappaB family member specificity, rather than determining the ability of a particular dimer to bind effectively, the sequence affects which coactivators will form productive interactions with the bound NF-kappaB dimer. This suggests that binding sites may impart a specific configuration to bound transcription factors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315758     DOI: 10.1016/j.cell.2004.08.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  173 in total

Review 1.  Selectivity of the NF-{kappa}B response.

Authors:  Ranjan Sen; Stephen T Smale
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-14       Impact factor: 10.005

2.  The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Authors:  Pengyuan Yang; Huazhang An; Xingguang Liu; Mingyue Wen; Yuanyuan Zheng; Yaocheng Rui; Xuetao Cao
Journal:  Nat Immunol       Date:  2010-05-09       Impact factor: 25.606

3.  HIV develops indirect cross-resistance to combinatorial RNAi targeting two distinct and spatially distant sites.

Authors:  Priya S Shah; Nhung P Pham; David V Schaffer
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

Review 4.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

Review 5.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

6.  The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.

Authors:  Aurore Keutgens; Kateryna Shostak; Pierre Close; Xin Zhang; Benoît Hennuy; Marie Aussems; Jean-Paul Chapelle; Patrick Viatour; André Gothot; Marianne Fillet; Alain Chariot
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

7.  IkappaBeta, a nuclear IkappaB protein, positively regulates the NF-kappaB-mediated expression of proinflammatory cytokines.

Authors:  Shumpei Yamauchi; Hiroaki Ito; Atsushi Miyajima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

8.  Challenges in studying phospholipid signaling.

Authors:  Carsten Schultz
Journal:  Nat Chem Biol       Date:  2010-07       Impact factor: 15.040

9.  Extensive cooperation of immune master regulators IRF3 and NFκB in RNA Pol II recruitment and pause release in human innate antiviral transcription.

Authors:  Jonathan E Freaney; Rebecca Kim; Roli Mandhana; Curt M Horvath
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

10.  Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression.

Authors:  Kim Ravnskjaer; Henri Kester; Yi Liu; Xinmin Zhang; Dong Lee; John R Yates; Marc Montminy
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.